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Letter to the Editor
of newly registered patients at 2 outpatient facilities in Amsterdam 
(The Netherlands) of age 18–65 years with a DSM-IV-defined ma-
jor depressive disorder of mild to moderate severity. SPSP involves 
an open patient-therapist dialogue that uses supportive and in-
sight-facilitating techniques to address the emotional background 
of depression and was delivered in 16 sessions of 45 min within a 
24-week period. In the combined condition, antidepressants were 
provided for 24 weeks according to a protocol with several steps in 
case of intolerance or inefficacy: first venlafaxine, followed by 
fluoxetine, and finally nortriptyline. Sixteen depressive symptoms 
were assessed at baseline and after 24 weeks with the depression 
subscale of the Symptom Checklist-90. Analyses were conducted 
in a sample consisting of all patients who started with the treatment 
they were allotted to (psychotherapy, 
n = 103; combined therapy, n = 83; see the online suppl. material 
for the sample characteristics; for all online suppl. material, see 
www.karger.com/doi/10.1159/000486793) and the last outcome 
carried forward method was applied. First, we focused on the rela-
tive efficacy of psychotherapy versus combined therapy by using 
individual symptoms as effect parameters and, then, differentiated 
between direct and indirect effects by taking into account symp-
tom interrelatedness in a network model.
Symptom-specific efficacy of psychotherapy versus combined 
therapy was investigated using independent sample t tests with 
change scores (post- minus pre-treatment) of depressive symp-
toms as dependent variables. Combined therapy was significantly 
more effective than psychotherapy in decreasing the symptoms 
feeling entrapped (Cohen’s d = 0.55, p < 0.001), emotional lability 
(Cohen’s d = 0.47, p = 0.002), worry (Cohen’s d = 0.44, p = 0.003), 
hopelessness (Cohen’s d = 0.41, p = 0.006), obsessive thoughts (Co-
hen’s d = 0.34, p = 0.02), blue mood (Cohen’s d = 0.32, p = 0.03), 
and low in energy (Cohen’s d = 0.31, p = 0.04). The remaining 9 
symptoms showed similar responses to psychotherapy and com-
bined therapy (Fig. 1).
Then, we took into account symptom interrelatedness to dif-
ferentiate between the direct and indirect effects of the addition of 
pharmacotherapy to psychotherapy. An L1-regularized partial 
correlation network of treatment type and change scores of all de-
pressive symptoms was estimated (the network estimation proce-
dure and tests for parameter estimate accuracy are described in the 
online suppl. material). Figure 1 shows that changes in depressive 
symptoms during treatment were strongly related. The strongest 
association was found between thoughts of death and thoughts of 
suicide (partial correlation = 0.49), indicating that persons with an 
improvement in thoughts of death during treatment were more 
likely to experience an improvement in thoughts of suicide as well. 
Treatment type showed the strongest direct connections to feeling 
entrapped (partial correlation = 0.16) and emotional lability (par-
tial correlation = 0.11), and was weakly connected to worry (partial 
correlation = 0.04), low in energy (partial correlation = 0.01), and 
hopelessness (partial correlation = 0.01). All connections were in 
A number of studies have reported that adding pharmacother-
apy to psychotherapy has no or only small advantages in the treat-
ment of mild to moderate depression [1–3]. These studies have 
used sum scores of depression rating scales as effect parameters 
[1–3]. However, as individual items on these scales have recently 
been shown to respond differentially to pharmacotherapy com-
pared to placebo [4], the effects of an addition of pharmacotherapy 
to psychotherapy may only be detectable by focusing on individu-
al depressive symptoms. 
Previous studies investigating treatment responses of individ-
ual depressive symptoms (e.g., Hieronymus et al. [4]) did not take 
into account the potential interrelatedness of these symptoms. For 
example, patients who become less self-blaming in response to 
treatment may also be more likely to experience reductions in feel-
ings of worthlessness or blue mood. Tools to consider symptom 
interrelatedness are offered by the network approach, which con-
ceptualizes depression as a system of associated symptoms [5]. 
Earlier network studies have demonstrated that depressive symp-
toms are differentially related to one another [5–7]; however, it 
remains unknown if similar association patterns exist among 
changes in these symptoms during treatment. Taking into account 
these relations in a network structure provides the opportunity to 
determine the effects of adjunctive pharmacotherapy on specific 
symptoms while adjusting for responses of other symptoms. This 
enables a differentiation between direct symptom-specific effects 
(i.e., those independent of changes in other symptoms) and indi-
rect symptom-specific effects (i.e., those mediated by changes in 
other symptoms).
This is the first study to determine the relative efficacy of psy-
chotherapy versus combined therapy on individual depressive 
symptoms. Data were derived from a randomized controlled trial 
comparing short-term psychodynamic supportive psychotherapy 
(SPSP) and this therapy combined with pharmacotherapy in pa-
tients with mild to moderate depression [1]. Participants consisted 
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favor of combined therapy, suggesting that this therapy targeted 
these particular symptoms directly.
Despite their significant responses to the addition of pharma-
cotherapy to psychotherapy in our first analysis, obsessive thoughts 
and blue mood were not directly connected to treatment type in 
the network, and worry, low in energy, and hopelessness showed 
only weak direct associations to this variable. Interestingly, the net-
work revealed that these symptoms were related to changes in feel-
ing entrapped and emotional lability, which in turn were more 
strongly connected to the type of treatment. This suggests that the 
effect of adjunctive pharmacotherapy on obsessive thoughts, blue 
mood, worry, low in energy, and hopelessness may largely have 
been indirect and could have been mediated by changes in feeling 
entrapped and emotional lability. 
A strength of this study is that the trial included a fairly random 
and representative sample of mildly to moderately depressed pa-
tients in secondary care. Furthermore, we estimated the network 
structure using l1-regularization to prevent overfitting, which has 
been shown to adequately control for false positive associations. 
However, in our relatively small sample of 186 individuals, small 
true positive associations could have been overlooked [8]. As base-
line scores in our sample differed across symptoms, it is also im-
portant to note that a higher baseline severity of symptoms was 
associated with stronger responses to adjunctive pharmacothera-
py, which is in line with previous reports [2].
In conclusion, this study showed that combined therapy out-
performed psychotherapy in the treatment of some depressive 
symptoms and not others. Although our results are exploratory 
rather than conclusive, they suggest that adjunctive pharmaco-
therapy targeted specific symptoms (e.g., feeling entrapped, emo-
tional lability) directly and other symptoms (e.g., obsessive 
thoughts, blue mood) indirectly. As direct effects are independent 
of changes in other symptoms, our findings imply that adjunctive 
pharmacotherapy can effectuate improvements in directly target-
ed symptoms in all patients irrespective of changes in other symp-
toms. Indirectly targeted symptoms, in contrast, may respond to 
an addition of pharmacotherapy to psychotherapy, but only in pa-
tients improving on symptoms mediating these responses during 
treatment and, therefore, reporting these symptoms before treat-
ment. If replicated, these insights may help clinicians to predict 
which patients could benefit from an addition of pharmacotherapy 
to psychotherapy [9]. 
Given the differential treatment responses across symptoms, 
we would like to encourage other researchers to analyze individu-
al depressive symptoms as well as their interrelatedness. Network 
models are highly promising in this approach as they can be ex-
panded with other psychiatric or physical symptoms (e.g., anxiety, 
nausea) to provide insight into secondary or side effects of a treat-
ment independent of its effects on depressive symptoms. Further-
more, dynamic networks of depressive symptoms during various 
treatment stages could reveal that changes in specific symptoms 
are preceded by changes in other symptoms, which may inform on 
pathways underlying indirect responses of symptoms to a treat-
ment [10].
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Fig. 1. Symptom-specific effects of psycho-
therapy versus combined therapy. The type 
of treatment is represented by the square 
and depressive symptoms by circles. Rela-
tive effect sizes of psychotherapy versus 
combined therapy on specific symptoms 
(all in favor of combined therapy) are indi-
cated by the size of circles and their level of 
significance by circle color (violet is signif-
icant and white is nonsignificant; colors 
online version only). Connections in the 
network model are represented by lines, of 
which the thickness is proportional to the 
strength of associations. Direct associa-
tions between the type of treatment and 
change scores of symptoms are all in favor 
of combined therapy (indicated by violet 
lines) and associations between change 
scores of symptoms are all positive (indi-
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